The Overactive Bladder (OAB) market is a subset of the Urology and Nephrology industry. OAB is a condition characterized by frequent urination, urgency, and urge incontinence. It is estimated that OAB affects up to 33% of adults worldwide. Treatment options for OAB include lifestyle modifications, medications, and neuromodulation.
The OAB market is expected to grow due to the increasing prevalence of OAB, the introduction of new treatments, and the increasing awareness of the condition. Additionally, the aging population is expected to drive the market growth.
Companies in the OAB market include Allergan, Astellas Pharma, Boston Scientific, Medtronic, and Coloplast. Show Less Read more
